Nephrotoxicity of cefotiam in rats.
Eight-week-old Wistar female rats were treated intramuscularly with 300, 1,000 and 3,000 mg/kg/day of cefotiam for five days. The nephrotoxicity of cefotiam was determined on the basis of the number of tubular epithelial cells excreted, the malate dehydrogenase activity in the urine and the histological examination of the kidneys. Cephalothin (3,000 mg/kg/day) was used as a reference compound. There were slight increases in the number of tubular epithelial cells excreted and in the malate dehydrogenase activity in the urine of some animals receiving 3,000 mg/kg/day of cefotiam or cephalothin. All of these changes disappeared within a few days after the dosing period. The histological examination of the kidneys at the end of both the dosing (5 days) and the recovery (7 days) periods revealed no pathological changes indicating nephrotoxicity. It was concluded that the nephrotoxicity of cefotiam was comparable to that of cephalothin; the urinary changes in animals receiving the highest dose were considered to be an early sign of nephrotoxicity. The maximum non-toxic dose of cefotiam was 1,000 mg/kg/day under the present experimental conditions.
D000818:Animals; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000633:toxicity; D015310:Cefotiam; D003594:Cytoplasmic Granules / Q000648:ultrastructure; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells; D005260:Female; D007668:Kidney / Q000187:drug effects*; D007684:Kidney Tubules / Q000166:cytology; D007687:Kidney Tubules, Proximal / Q000648:ultrastructure; D008291:Malate Dehydrogenase / Q000652:urine; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D014556:Urine / Q000166:cytology
D015310:Cefotiam; D008291:Malate Dehydrogenase; D002439:Cefotaxime